Acrivon Therapeutics, Inc. Common Stock

ACRVNASDAQ • USD
1.43 USD
↘ 0.02 (1.38%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Acrivon Therapeutics, Inc. Common Stock (ACRV) trades at $1.43 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, ACRV appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.43
High?$1.63
Low?$1.41
Prev. Close?$1.45
Volume?205.3K
Avg. Volume?213.7K
VWAP?$1.43
Rel. Volume?0.96x
Bid / Ask
Bid?$1.40 × 200
Ask?$1.44 × 300
Spread?$0.04
Midpoint?$1.42
Valuation & Ratios
Market Cap?62.1M
Shares Out?42.9M
Float?24.2M
Float %?56.5%
P/E Ratio?N/A
P/B Ratio?0.72
EPS?-$1.73
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.
Employees
76
Market Cap
62.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-11-15
Address
480 ARSENAL WAY, SUITE 100
WATERTOWN, MA 02472
Phone: 617-207-8979
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.05Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?7.46%Elevated
Short Interest?1.8M
Days to Cover?11.4
Free Float24.2M
Avg Daily Volume158.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?7.99Strong
Quick Ratio?7.99Strong
Cash Ratio?3.62Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.72CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-85.7%WEAK▾
ROA?
S&P
3
-74.9%WEAK▾
Cash Flow & Enterprise
FCF?$-64139000
Enterprise Value?$20.7M
Fundamentals ratios updated end of day